Gilead Sciences Inc on Thursday said that the marketing authorisation in Japan for its chimeric antigen receptor T-ce ...
The following is a round-up of updates by global companies, issued on Tuesday and not separately reported by Alliance ...
The World Health Organization said Friday it "strongly recommended" Pfizer Inc's covid-19 antiviral pill Paxlovid for ...
GlaxoSmithKline PLC on Wednesday said majority-owned investee ViiV Healthcare has agreed to settle a global patent in ...
Gilead Sciences Inc on Friday said that the US Food & Drug Administration granted its Veklury drug expedited approval ...
Gilead Sciences Inc and Merck & Co Inc announced Tuesday the start of a Phase 2 clinical study evaluating an investig ...
Gilead Sciences Inc on Tuesday said it has entered into a clinical collaboration with Vir Biotechnology Inc focused o ...
Gilead Sciences Inc on Monday said it has increased its product sales guidance for 2020 as one of its drugs used to t ...
Kite, a Gilead Sciences Inc portfolio company, on Wednesday said it and Oxford BioTherapeutics Ltd have entered into ...
Gilead Sciences Inc on Wednesday noted the conditional marketing authorisation of Tecartus as a treatment for relapse ...
Gilead Sciences Inc said Thursday it has agreed to buy German biotechnology company MYR GmBH for EUR1.15 billion in c ...
The anti-viral drug remdesivir should not be used to treat Covid-19 patients no matter how severe their illness as it ...
Gilead Sciences Inc's anti-viral drug remdesivir should not be used to treat Covid-19 patients no matter how severe t ...
Gilead Sciences Inc on Wednesday posted a double-digit revenue hike in its third quarter but slightly lowered the upp ...
Gilead Sciences Inc said late Thursday its antiviral drug Veklury, also known as remdesivir has been approved by the ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
News
Market Data
Register to chat with like-minded investors on our interactive forums.
